Skip Navigation

Adult Leukemia Program Treatment Team

  • Our highly focused and experienced team of physicians, practitioners, and clinical researchers work to provide state-of-the-art compassionate care with an emphasis on cutting-edge clinical research. Physicians work closely with research scientists in a "bench-to-bedside" approach that identifies promising new treatments by rapidly translating laboratory discoveries into the clinical setting.

    Adult Leukemia Program Leadership

    Daniel J. DeAngelo, MD, PhD, Chief, Division of Leukemia

    Richard M. Stone, MD, Chief of Staff; Director, Translational Research, Leukemia Program          
    David Steensma, MD, Clinical Director, Center for Prevention of Progression
    Martha Wadleigh, MD, Clinical Director